Flat feet, medically known as pes planus or fallen arches, is a common condition affecting millions of people worldwide. Characterized by the collapse of the arch of the foot, this condition occurs when the subtalar joint — the joint that connects the heel bone to the ankle — becomes misaligned. While many individuals with flat feet experience no symptoms, a significant portion suffer from chronic pain in the feet, ankles, knees, hips, and lower back. For decades, treatment options were largely limited to orthotics, physical therapy, and in severe cases, invasive reconstructive surgery. The advent of HyProCure, a minimally invasive surgical procedure, has offered a new and increasingly popular solution. This essay explores the nature of flat feet, the mechanism and procedure of HyProCure, its benefits, risks, and its standing as a modern treatment option.

Understanding Flat Feet and Their Impact

The human foot is a remarkable architectural structure, designed to bear weight, absorb shock, and provide balance. Central to its function is the medial longitudinal arch, the curved structure running along the inner edge of the foot. In a healthy foot, this arch rises off the ground, distributing weight evenly across the heel and ball of the foot. In individuals with flat feet, this arch is absent or severely diminished, causing the entire sole to make contact with the ground. The root cause of many flat feet cases is hyperpronation — an excessive inward rolling motion of the ankle and foot during walking or standing. This misalignment places abnormal stress not only on the foot itself but on the entire kinetic chain, from the ankles and knees up through the hips and spine. Symptoms associated with flat feet and hyperpronation include heel pain, plantar fasciitis, shin splints, bunions, hammertoes, knee pain, and fatigue during prolonged standing or walking. Left untreated, chronic hyperpronation can lead to degenerative joint disease and long-term mobility issues.

What Is HyProCure?

HyProCure is the brand name for a stent-based, minimally invasive surgical procedure developed to correct hyperpronation and the structural misalignment that causes flat feet. The procedure involves the insertion of a small titanium stent into the sinus tarsi — a naturally occurring canal located between the ankle bone (talus) and the heel bone (calcaneus). By placing this stent in the sinus tarsi, the device acts as a physical spacer that prevents the ankle from rolling excessively inward while still allowing normal foot movement. The HyProCure system was cleared by the U.S. Food and Drug Administration (FDA) and has been used in hundreds of thousands of procedures globally. It is designed to be a permanent solution, though the stent can be removed if necessary. The procedure addresses the condition at its anatomical root rather than merely managing symptoms, which distinguishes it from conservative approaches such as orthotics.

The Surgical Procedure

One of the most significant advantages of the HyProCure procedure is its minimally invasive nature. The surgery is typically performed on an outpatient basis under local or general anesthesia and takes approximately 20 to 30 minutes per foot. The surgeon makes a small incision — usually less than one centimeter — on the outer side of the foot to access the sinus tarsi canal. The correctly sized stent is then inserted into this space, gently realigning the talus bone over the calcaneus and restoring normal subtalar joint position. Because the procedure does not involve cutting or removing bone, it is far less traumatic than traditional flat foot reconstructive surgeries, which often require osteotomies (bone cuts), bone grafts, and long recovery periods. Following the HyProCure procedure, patients are typically able to bear weight within days, with full recovery — including return to athletic activity — generally occurring within four to eight weeks. Post-operative care includes wearing a surgical boot, physical therapy, and follow-up imaging to confirm proper stent placement.

Benefits of HyProCure

The benefits of the HyProCure procedure are numerous and well-documented in clinical literature. Foremost among them is the immediate correction of subtalar joint misalignment, which can provide rapid and significant relief from pain and discomfort. Many patients report a dramatic improvement in quality of life, including reduced foot and ankle pain, better balance, improved posture, and relief from secondary conditions such as knee and lower back pain. Unlike orthotics, which must be worn continuously to maintain their effect, HyProCure provides a structural correction that remains effective whether or not the patient is wearing supportive footwear. This makes it particularly appealing for active individuals, athletes, and children whose feet are still developing. Studies have shown that correcting hyperpronation at a young age can prevent the long-term complications associated with flat feet and may reduce the risk of developing conditions such as bunions, plantar fasciitis, and arthritis later in life. Additionally, the procedure's reversibility offers patients peace of mind, as the stent can be removed without permanent alteration to the foot's anatomy.

Risks and Considerations

As with any surgical intervention, HyProCure carries potential risks and is not suitable for every patient. The most commonly reported complication is stent displacement or discomfort, which occurs when the body does not tolerate the implant or the stent migrates from its intended position. In these cases, the stent must be removed or repositioned. Some patients also experience soft tissue irritation, swelling, or a sensation of pressure in the sinus tarsi area, particularly during the initial healing phase. Patient selection is critical to achieving successful outcomes. HyProCure is generally most effective for patients with flexible flat feet — cases where the arch can be manually corrected — as opposed to rigid flat feet caused by tarsal coalition or advanced arthritis. A thorough pre-operative evaluation, including gait analysis, imaging studies, and physical examination, is essential to determine candidacy. Critics of the procedure also note that long-term, large-scale studies are still needed to fully establish efficacy and complication rates across diverse patient populations.

HyProCure represents a significant advancement in the treatment of flat feet and the underlying problem of subtalar joint misalignment. Its minimally invasive nature, short recovery time, and ability to address the structural cause of hyperpronation make it an attractive option for patients who have not found relief through conservative measures. While it is not a universal solution and carries its own set of risks, the procedure has transformed the management of flat feet for many individuals across the world. As surgical techniques continue to evolve and long-term data accumulates, HyProCure is likely to become an even more central tool in the podiatric and orthopedic surgeon's repertoire, offering renewed mobility and pain relief to those whose lives have been limited by flat feet.

The Chevron osteotomy stands as one of the most widely performed and well-established surgical procedures for the correction of mild to moderate hallux valgus, commonly known as bunions. This distal metatarsal osteotomy, characterized by its distinctive V-shaped cut, has evolved over decades to become a cornerstone technique in foot and ankle surgery, offering predictable outcomes with relatively low complication rates when applied to appropriate cases.

Understanding Bunions and Surgical Indications

Hallux valgus represents a complex three-dimensional deformity of the first metatarsophalangeal joint, characterized by lateral deviation of the great toe and medial deviation of the first metatarsal head. This progressive condition affects approximately 23% of adults aged 18-65 and up to 36% of those over 65, causing pain, difficulty with footwear, and cosmetic concerns. While conservative measures including wider shoes, padding, and orthotic devices may provide symptomatic relief, surgical intervention becomes necessary when pain significantly impairs quality of life and non-operative treatments have failed.

The Chevron osteotomy is specifically indicated for mild to moderate bunion deformities, typically defined as an intermetatarsal angle between 11 and 16 degrees and a hallux valgus angle less than 40 degrees. Patients with severe deformities, significant arthritis, or elderly individuals with poor bone quality may require alternative procedures. The ideal candidate is a healthy patient with good bone quality, realistic expectations, and symptomatic bunion deformity that interferes with daily activities.

Surgical Technique and Biomechanical Principles

The Chevron osteotomy derives its name from its V-shaped configuration, which resembles the military insignia. The procedure involves creating a 60-degree V-shaped cut in the distal first metatarsal head, with the apex positioned at the center of the metatarsal head. This geometric design provides inherent stability while allowing for lateral displacement of the metatarsal head to correct the deformity.

The surgical approach typically begins with a medial incision over the first metatarsophalangeal joint. After careful dissection and protection of neurovascular structures, the medial eminence prominence is exposed. The surgeon then creates the characteristic V-shaped osteotomy using an oscillating saw, with the dorsal and plantar arms of the osteotomy extending proximally at equal angles. The distal capital fragment is then translated laterally, typically 3-5 millimeters, to reduce the intermetatarsal angle and realign the metatarsal head over the sesamoid bones.

The medial eminence is resected flush with the medial cortex of the metatarsal shaft, removing the bony prominence that characterizes the bunion deformity. The osteotomy is secured using various fixation methods, most commonly a single or double screw fixation, though some surgeons utilize Kirschner wires or absorbable pins. The medial capsule is then carefully repaired and imbricated to provide additional soft tissue stabilization.

Biomechanical Advantages

The Chevron osteotomy offers several biomechanical advantages that contribute to its widespread adoption. The V-shaped configuration creates a large surface area of bone contact, promoting rapid healing and inherent stability. The interlocking nature of the osteotomy resists dorsal and plantar displacement, reducing the risk of malunion. Additionally, the distal location of the cut preserves blood supply to the metatarsal head, minimizing the risk of avascular necrosis.

The procedure effectively addresses the fundamental deformity by lateralizing the metatarsal head, thereby reducing the intermetatarsal angle and improving weight distribution across the forefoot. The geometric design allows for predictable correction while maintaining the overall length of the first metatarsal, preserving proper biomechanics of the first ray. This preservation of length is crucial for maintaining appropriate pressure distribution during gait and preventing transfer metatarsalgia.

Clinical Outcomes and Evidence

Extensive research has demonstrated the efficacy of the Chevron osteotomy for appropriate bunion deformities. Patient satisfaction rates consistently exceed 85-90%, with significant improvements in pain scores and functional outcomes. Radiographic studies show reliable correction of the hallux valgus angle and intermetatarsal angle, with most series reporting recurrence rates below 10% when proper patient selection criteria are followed.

The procedure typically allows for early protected weight-bearing in a surgical shoe, with most patients returning to regular footwear within 6-8 weeks and resuming full activities by 3-4 months. The relatively short recovery period compared to more extensive procedures represents another significant advantage for appropriate candidates.

Complications and Limitations

While generally safe and effective, the Chevron osteotomy carries potential complications that must be discussed with patients. Avascular necrosis of the metatarsal head occurs in approximately 0-20% of cases across various studies, though symptomatic cases requiring revision are rare. Other potential complications include recurrence of deformity, hallux varus (overcorrection), transfer metatarsalgia, infection, nonunion, and nerve injury.

The primary limitation of the Chevron osteotomy lies in its corrective power. Because it is a distal osteotomy with limited translation capability, it cannot adequately correct severe deformities with intermetatarsal angles exceeding 16 degrees. Attempting to use this procedure for inappropriate cases increases the risk of recurrence and complications. Surgeons must carefully assess each patient’s deformity and select the appropriate procedure accordingly.

The Chevron osteotomy represents a time-tested, reliable solution for mild to moderate bunion deformities. Its elegant geometric design, inherent stability, predictable outcomes, and relatively low complication profile have established it as a gold standard in bunion surgery. Success depends critically on appropriate patient selection, meticulous surgical technique, and realistic patient expectations. When performed by experienced surgeons for properly indicated cases, the Chevron osteotomy continues to provide excellent pain relief, functional improvement, and patient satisfaction, maintaining its position as a cornerstone procedure in the armamentarium of foot and ankle surgeons worldwide.